查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1631514

皮肤科药物市场规模、份额、趋势分析报告：按治疗方法、类型、给药途径、药物类别、分销管道、地区和细分市场划分，预测，2025-2030 年

Dermatological Drugs Market Size, Share & Trends Analysis Report By Therapy (Acne, Psoriasis, Rosacea), By Type, By Route Of Administration, By Drug Class, By Distribution Channel, By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10个工作天内

价格

皮肤科药物市场的成长与趋势

根据 Grand View Research, Inc. 的一份新报告，全球皮肤病治疗市场预计到 2030 年将达到 423 亿美元，2025 年至 2030 年期间的复合年增长率为 10.1%。全球皮肤病药物市场预计将增长，其驱动因素包括用于检测和治疗皮肤病的医疗资源的可用性、不健康的饮食习惯导致的营养缺乏、对文明病的认识不断提高、污染水平上升以及人口免疫力。此外，人均收入的增加和购买力的增强正在推动这一市场的发展。

预计 2022 年至 2028 年期间痤疮领域复合年增长率将达到 10.5%。痤疮是一种皮肤病，皮肤中的死皮和油腺被堵塞，导致斑点、粉刺，有时还会导致囊肿。此外，受感染的毛囊会导致皮肤毛孔中出现痤疮。痤疮会导致脸部、肩部、胸部和背部出现粉刺、黑头和白斑等肿块。痤疮可以透过皮肤科医生的有效治疗治愈，同时还可以改善皮肤外观，从而促进皮肤病药物市场的发展。

2021 年，北美占最大的销售份额，超过 35%。美国正在为该地区市场的成长做出积极贡献。知名医药供应商的存在是支持市场成长的关键因素之一。该地区是医疗基础设施和先进研发活动方面推出新技术的有希望的地区之一，这将有助于创新和生产治疗癌症的最佳药物。该地区的医疗保健行业正在经历从传统护理向消费者主导的快速转变，以提供诊断和基于交付的医疗保健服务。此外，医疗保健产业的药品供应和患者的报销政策也有助于推动该地区市场的发展。

皮肤科药物市场报告重点

  • 干癣领域占据市场主导地位，2024 年的收入份额最大，为 50.6%。这是由于人们对该疾病的认识和对有效治疗的需求。
  • 处方药部门将在 2024 年占据市场主导地位，占据 61.9% 的最大收益占有率，预计在预测期内以 10.4% 的最快复合年增长率增长。
  • 局部用药占市场主导地位，2024 年销售份额最大，为 60.0%。
  • 皮质类固醇占市场主导地位，2024 年销售份额最大，为 30.1%。这是由于皮肤感染疾病患者的数量不断增加以及研究和开发的增长。
  • 零售药局将占据市场主导地位，2024 年的销售份额最大，为 50.6%。这是由于非处方皮肤病产品的增长和人们对皮肤病的认识的提高。
  • 2024 年北美皮肤病药物市场占据主导地位，收入份额最大，为 38.6%。
  • 2024 年北美皮肤病药物市场占最大收入份额，为 33.6%。

目录

第一章调查方法与范围

第 2 章执行摘要

3. 皮肤科药物市场变数、趋势和范围

  • 市场介绍/电网展望
  • 市场规模和成长前景
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
  • 皮肤科药物市场分析工具
    • 波特的分析
    • PESTEL 分析

第 4 章 皮肤科药物市场：治疗方法进行估计和趋势分析

  • 2024 年和 2030 年治疗方法市场占有率
  • 治疗方法细分仪表板
  • 2018 年至 2030 年按治疗方法的市场规模、预测与趋势分析
  • 粉刺
  • 干癣
  • 酒糟样皮肤炎
  • 脱髮症
  • 其他的

第 5 章皮肤病药物市场：按类型估计和趋势分析

  • 2024 年及 2030 年类型市场占有率
  • 类型细分仪表板
  • 2018 年至 2030 年按类型分類的市场规模、预测与趋势分析
  • 处方笺
  • 场外交易（OTC）

第六章 皮肤科药物市场：依给药途径的估计与趋势分析

  • 2024 年及 2030 年给药途径市场占有率
  • 给药途径细分仪表板
  • 2018 年至 2030 年按给药途径分類的市场规模、预测和趋势分析
  • 局部给药
  • 口服
  • 肠外给药

7. 皮肤科药物市场：药物类别、估计与趋势分析

  • 2024 年及 2030 年药物类别市场占有率
  • 药品类别细分仪表板
  • 2018 年至 2030 年按药物类别分類的市场规模、预测和趋势分析
  • 皮质类固醇
  • 类视色素
  • 抗生素
  • 抗真菌药物
  • Calcineurin抑制剂
  • 其他的

第 8 章：皮肤科药物市场：按分销管道进行的估计和趋势分析

  • 分销通路市场占有率，2024 年和 2030 年
  • 分销通路细分仪表板
  • 2018 年至 2030 年按分销管道分類的市场规模、预测和趋势分析
  • 医院药房
  • 零售药局
  • 其他的

第九章皮肤科药物市场：按地区分類的估计和趋势分析

  • 2024 年及 2030 年区域市场占有率分析
  • 区域市场仪表板
  • 2018-2030 年市场规模及预测趋势分析
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 丹麦
    • 瑞典
    • 挪威
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 澳洲
    • 韩国
    • 泰国
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第十章 竞争格局

  • 参与者概述
  • 企业市场分析
  • 公司分类
  • 战略地图
  • 公司简介/上市公司
    • AbbVie Inc.
    • Pfizer Inc.
    • GSK plc.
    • Sun Pharmaceutical Industries Ltd.
    • GALDERMA
    • Amgen Inc.
    • Johnson & Johnson Services, Inc.
    • Novartis AG
    • Eli Lilly and Company
    • Almirall, SA
    • Bausch Health Companies Inc.
Product Code: GVR-4-68039-934-2

Dermatological Drugs Market Growth & Trends:

The global dermatological drugs market size is expected to reach USD 42.3 billion by 2030, expanding at a CAGR of 10.1% from 2025 to 2030, according to a new report by Grand View Research, Inc. The global dermatological drugs market is expected to grow due to driving factors such as the availability of medical resources for detecting and treating skin diseases, nutritional deficiency due to unhealthy food habits, increasing awareness when it comes to lifestyle diseases, and increasing pollution levels, and lack of immunity in the population. Additionally, the rising per capita income and the increasing purchasing power are the driving forces in this market.

The acne segment is expected to expand with a CAGR of 10.5% from 2022 to 2028. Acne is a skin condition where dead skin and oil glands of skin glands are clogged, forming spots, pimples, and sometimes cysts. Additionally, infected hair follicles cause acne, which starts from the skin's pores. Acne causes bumps on the face, shoulders, chest, and back in the form of pimples, blackheads, and whiteheads. Acne can be cured, and the appearance of the skin can be improved with effective treatment from dermatologists, contributing to the dermatological drug market.

North America held the largest revenue share of more than 35% in 2021. The U.S. is positively contributing to the growth of the regional market. The presence of well-established pharmaceutical vendors is one of the key factors supporting the market growth. This region is one of the promising regions to launch new technology in terms of healthcare infrastructure and advanced research and development activities that help innovate and produce the most appropriate drugs to cure cancer. It is observed that in the region, there is a rapid shift in the healthcare industry to consumer-driven from traditional treatment for providing diagnosis and provision-based health services. Additionally, ease of availability of drugs and reimbursement policies for the patient in the healthcare industry contributes to driving the market in the region.

Dermatological Drugs Market Report Highlights:

  • The psoriasis segment dominated the market with the largest revenue share of 50.6% in 2024, which can be attributed to the awareness of the disease and the demand for effective treatments.
  • The prescription segment dominated the market for the largest revenue share of 61.9% in 2024 and is expected to grow over the fastest CAGR of 10.4% over the forecast period.
  • Topical administration dominated the market with the largest revenue share of 60.0% in 2024.
  • Corticosteroids dominated the market with the largest revenue share of 30.1% in 2024. This can be attributed to rising skin infection cases and the growth of research and development.
  • Retail pharmacies dominated the market, with the largest revenue share of 50.6% in 2024. This can be attributed to OTC dermatological product growth and awareness of skin conditions.
  • The dermatological drugs market in North America dominated the market with the largest revenue share of 38.6% in 2024, which can be attributed to advancements in drug development and increasing awareness.
  • The North America Dermatological Drugs market had the largest revenue share of 33.6% in 2024.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
  • 1.3. Research Methodology
    • 1.3.1. Information Procurement
    • 1.3.2. Information or Data Analysis
    • 1.3.3. Market Formulation & Data Visualization
    • 1.3.4. Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1. List of Data Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Dermatological Drugs Market Variables, Trends, & Scope

  • 3.1. Market Introduction/Lineage Outlook
  • 3.2. Market Size and Growth Prospects (USD Million)
  • 3.3. Market Dynamics
    • 3.3.1. Market Drivers Analysis
    • 3.3.2. Market Restraints Analysis
  • 3.4. Dermatological Drugs Market Analysis Tools
    • 3.4.1. Porter's Analysis
      • 3.4.1.1. Bargaining Power of the Suppliers
      • 3.4.1.2. Bargaining Power of the Buyers
      • 3.4.1.3. Threats of Substitution
      • 3.4.1.4. Threats from New Entrants
      • 3.4.1.5. Competitive Rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political Landscape
      • 3.4.2.2. Economic and Social Landscape
      • 3.4.2.3. Technological Landscape
      • 3.4.2.4. Environmental Landscape
      • 3.4.2.5. Legal Landscape

Chapter 4. Dermatological Drugs Market: Therapy Estimates & Trend Analysis

  • 4.1. Therapy Market Share, 2024 & 2030
  • 4.2. Therapy Segment Dashboard
  • 4.3. Market Size & Forecasts and Trend Analysis, by Therapy, 2018 to 2030 (USD Million)
  • 4.4. Acne
    • 4.4.1. Acne Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.5. Psoriasis
    • 4.5.1. Psoriasis Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.6. Rosacea
    • 4.6.1. Rosacea Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.7. Alopecia
    • 4.7.1. Alopecia Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.8. Others
    • 4.8.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Dermatological Drugs Market: Type Estimates & Trend Analysis

  • 5.1. Type Market Share, 2024 & 2030
  • 5.2. Type Segment Dashboard
  • 5.3. Market Size & Forecasts and Trend Analysis, by Type, 2018 to 2030 (USD Million)
  • 5.4. Prescription
    • 5.4.1. Prescription Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.5. Over-the-counter (OTC)
    • 5.5.1. Over-the-counter (OTC) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Dermatological Drugs Market: Route of Administration Estimates & Trend Analysis

  • 6.1. Route of Administration Market Share, 2024 & 2030
  • 6.2. Route of Administration Segment Dashboard
  • 6.3. Market Size & Forecasts and Trend Analysis, by Route of Administration, 2018 to 2030 (USD Million)
  • 6.4. Topical Administration
    • 6.4.1. Topical Administration Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5. Oral Administration
    • 6.5.1. Oral Administration Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6. Parenteral Administration
    • 6.6.1. Parenteral Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Dermatological Drugs Market: Drug Class Estimates & Trend Analysis

  • 7.1. Drug Class Market Share, 2024 & 2030
  • 7.2. Drug Class Segment Dashboard
  • 7.3. Market Size & Forecasts and Trend Analysis, by Drug Class, 2018 to 2030 (USD Million)
  • 7.4. Corticosteroids
    • 7.4.1. Corticosteroids Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5. Retinoids
    • 7.5.1. Retinoids Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6. Antibiotics
    • 7.6.1. Antibiotics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.7. Antifungals
    • 7.7.1. Antifungals Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.8. Calcineurin Inhibitors
    • 7.8.1. Calcineurin Inhibitors Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.9. Others
    • 7.9.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Dermatological Drugs Market: Distribution Channel Estimates & Trend Analysis

  • 8.1. Distribution Channel Market Share, 2024 & 2030
  • 8.2. Distribution Channel Segment Dashboard
  • 8.3. Market Size & Forecasts and Trend Analysis, by Distribution Channel, 2018 to 2030 (USD Million)
  • 8.4. Hospital Pharmacies
    • 8.4.1. Hospital Pharmacies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.5. Retail Pharmacies
    • 8.5.1. Retail Pharmacies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.6. Others
    • 8.6.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 9. Dermatological Drugs Market: Regional Estimates & Trend Analysis

  • 9.1. Regional Market Share Analysis, 2024 & 2030
  • 9.2. Regional Market Dashboard
  • 9.3. Market Size & Forecasts Trend Analysis, 2018 to 2030:
  • 9.4. North America
    • 9.4.1. North America Dermatological Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.4.2. U.S.
      • 9.4.2.1. Key Country Dynamics
      • 9.4.2.2. Regulatory Framework
      • 9.4.2.3. Competitive Insights
      • 9.4.2.4. U.S. Dermatological Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.4.3. Canada
      • 9.4.3.1. Key Country Dynamics
      • 9.4.3.2. Regulatory Framework
      • 9.4.3.3. Competitive Insights
      • 9.4.3.4. Canada Dermatological Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.4.4. Mexico
      • 9.4.4.1. Key Country Dynamics
      • 9.4.4.2. Regulatory Framework
      • 9.4.4.3. Competitive Insights
      • 9.4.4.4. Mexico Dermatological Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 9.5. Europe
    • 9.5.1. Europe Dermatological Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.5.2. UK
      • 9.5.2.1. Key Country Dynamics
      • 9.5.2.2. Regulatory Framework
      • 9.5.2.3. Competitive Insights
      • 9.5.2.4. UK Dermatological Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.5.3. Germany
      • 9.5.3.1. Key Country Dynamics
      • 9.5.3.2. Regulatory Framework
      • 9.5.3.3. Competitive Insights
      • 9.5.3.4. Germany Dermatological Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.5.4. France
      • 9.5.4.1. Key Country Dynamics
      • 9.5.4.2. Regulatory Framework
      • 9.5.4.3. Competitive Insights
      • 9.5.4.4. France Dermatological Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.5.5. Italy
      • 9.5.5.1. Key Country Dynamics
      • 9.5.5.2. Regulatory Framework
      • 9.5.5.3. Competitive Insights
      • 9.5.5.4. Italy Dermatological Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.5.6. Spain
      • 9.5.6.1. Key Country Dynamics
      • 9.5.6.2. Regulatory Framework
      • 9.5.6.3. Competitive Insights
      • 9.5.6.4. Spain Dermatological Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.5.7. Denmark
      • 9.5.7.1. Key Country Dynamics
      • 9.5.7.2. Regulatory Framework
      • 9.5.7.3. Competitive Insights
      • 9.5.7.4. Denmark Dermatological Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.5.8. Sweden
      • 9.5.8.1. Key Country Dynamics
      • 9.5.8.2. Regulatory Framework
      • 9.5.8.3. Competitive Insights
      • 9.5.8.4. Sweden Dermatological Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.5.9. Norway
      • 9.5.9.1. Key Country Dynamics
      • 9.5.9.2. Regulatory Framework
      • 9.5.9.3. Competitive Insights
      • 9.5.9.4. Norway Dermatological Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 9.6. Asia Pacific
    • 9.6.1. Asia Pacific Dermatological Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.6.2. China
      • 9.6.2.1. Key Country Dynamics
      • 9.6.2.2. Regulatory Framework
      • 9.6.2.3. Competitive Insights
      • 9.6.2.4. China Dermatological Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.6.3. Japan
      • 9.6.3.1. Key Country Dynamics
      • 9.6.3.2. Regulatory Framework
      • 9.6.3.3. Competitive Insights
      • 9.6.3.4. Japan Dermatological Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.6.4. India
      • 9.6.4.1. Key Country Dynamics
      • 9.6.4.2. Regulatory Framework
      • 9.6.4.3. Competitive Insights
      • 9.6.4.4. India Dermatological Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.6.5. Australia
      • 9.6.5.1. Key Country Dynamics
      • 9.6.5.2. Regulatory Framework
      • 9.6.5.3. Competitive Insights
      • 9.6.5.4. Australia Dermatological Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.6.6. South Korea
      • 9.6.6.1. Key Country Dynamics
      • 9.6.6.2. Regulatory Framework
      • 9.6.6.3. Competitive Insights
      • 9.6.6.4. South Korea Dermatological Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.6.7. Thailand
      • 9.6.7.1. Key Country Dynamics
      • 9.6.7.2. Regulatory Framework
      • 9.6.7.3. Competitive Insights
      • 9.6.7.4. Thailand Dermatological Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 9.7. Latin America
    • 9.7.1. Latin America Dermatological Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.7.2. Brazil
      • 9.7.2.1. Key Country Dynamics
      • 9.7.2.2. Regulatory Framework
      • 9.7.2.3. Competitive Insights
      • 9.7.2.4. Brazil Dermatological Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.7.3. Argentina
      • 9.7.3.1. Key Country Dynamics
      • 9.7.3.2. Regulatory Framework
      • 9.7.3.3. Competitive Insights
      • 9.7.3.4. Argentina Dermatological Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 9.8. Middle East and Africa
    • 9.8.1. Middle East and Africa Dermatological Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.8.2. South Africa
      • 9.8.2.1. Key Country Dynamics
      • 9.8.2.2. Regulatory Framework
      • 9.8.2.3. Competitive Insights
      • 9.8.2.4. South Africa Dermatological Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.8.3. Saudi Arabia
      • 9.8.3.1. Key Country Dynamics
      • 9.8.3.2. Regulatory Framework
      • 9.8.3.3. Competitive Insights
      • 9.8.3.4. Saudi Arabia Dermatological Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.8.4. UAE
      • 9.8.4.1. Key Country Dynamics
      • 9.8.4.2. Regulatory Framework
      • 9.8.4.3. Competitive Insights
      • 9.8.4.4. UAE Dermatological Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.8.5. Kuwait
      • 9.8.5.1. Key Country Dynamics
      • 9.8.5.2. Regulatory Framework
      • 9.8.5.3. Competitive Insights
      • 9.8.5.4. Kuwait Dermatological Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 10. Competitive Landscape

  • 10.1. Participant Overview
  • 10.2. Company Market Position Analysis
  • 10.3. Company Categorization
  • 10.4. Strategy Mapping
  • 10.5. Company Profiles/Listing
    • 10.5.1. AbbVie Inc.
      • 10.5.1.1. Participant's Overview
      • 10.5.1.2. Financial Performance
      • 10.5.1.3. Product Benchmarking
      • 10.5.1.4. Recent Developments/ Strategic Initiatives
    • 10.5.2. Pfizer Inc.
      • 10.5.2.1. Participant's Overview
      • 10.5.2.2. Financial Performance
      • 10.5.2.3. Product Benchmarking
      • 10.5.2.4. Recent Developments/ Strategic Initiatives
    • 10.5.3. GSK plc.
      • 10.5.3.1. Participant's Overview
      • 10.5.3.2. Financial Performance
      • 10.5.3.3. Product Benchmarking
      • 10.5.3.4. Recent Developments/ Strategic Initiatives
    • 10.5.4. Sun Pharmaceutical Industries Ltd.
      • 10.5.4.1. Participant's Overview
      • 10.5.4.2. Financial Performance
      • 10.5.4.3. Product Benchmarking
      • 10.5.4.4. Recent Developments/ Strategic Initiatives
    • 10.5.5. GALDERMA
      • 10.5.5.1. Participant's Overview
      • 10.5.5.2. Financial Performance
      • 10.5.5.3. Product Benchmarking
      • 10.5.5.4. Recent Developments/ Strategic Initiatives
    • 10.5.6. Amgen Inc.
      • 10.5.6.1. Participant's Overview
      • 10.5.6.2. Financial Performance
      • 10.5.6.3. Product Benchmarking
      • 10.5.6.4. Recent Developments/ Strategic Initiatives
    • 10.5.7. Johnson & Johnson Services, Inc.
      • 10.5.7.1. Participant's Overview
      • 10.5.7.2. Financial Performance
      • 10.5.7.3. Product Benchmarking
      • 10.5.7.4. Recent Developments/ Strategic Initiatives
    • 10.5.8. Novartis AG
      • 10.5.8.1. Participant's Overview
      • 10.5.8.2. Financial Performance
      • 10.5.8.3. Product Benchmarking
      • 10.5.8.4. Recent Developments/ Strategic Initiatives
    • 10.5.9. Eli Lilly and Company
      • 10.5.9.1. Participant's Overview
      • 10.5.9.2. Financial Performance
      • 10.5.9.3. Product Benchmarking
      • 10.5.9.4. Recent Developments/ Strategic Initiatives
    • 10.5.10. Almirall, S.A
      • 10.5.10.1. Participant's Overview
      • 10.5.10.2. Financial Performance
      • 10.5.10.3. Product Benchmarking
      • 10.5.10.4. Recent Developments/ Strategic Initiatives
    • 10.5.11. Bausch Health Companies Inc.
      • 10.5.11.1. Participant's Overview
      • 10.5.11.2. Financial Performance
      • 10.5.11.3. Product Benchmarking
      • 10.5.11.4. Recent Developments/ Strategic Initiatives

List of Tables

  • Table 1. List of Secondary Sources
  • Table 2. List of Abbreviations
  • Table 3. Global Dermatological Drugs Market, by Region, 2018 - 2030 (USD Million)
  • Table 4. Global Dermatological Drugs Market, by Therapy, 2018 - 2030 (USD Million)
  • Table 5. Global Dermatological Drugs Market, by Type, 2018 - 2030 (USD Million)
  • Table 6. Global Dermatological Drugs Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 7. Global Dermatological Drugs Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 8. Global Dermatological Drugs Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 9. North America Dermatological Drugs Market, by Country, 2018 - 2030 (USD Million)
  • Table 10. North America Dermatological Drugs Market, by Therapy, 2018 - 2030 (USD Million)
  • Table 11. North America Dermatological Drugs Market, by Type, 2018 - 2030 (USD Million)
  • Table 12. North America Dermatological Drugs Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 13. North America Dermatological Drugs Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 14. North America Dermatological Drugs Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 15. U.S. Dermatological Drugs Market, by Therapy, 2018 - 2030 (USD Million)
  • Table 16. U.S. Dermatological Drugs Market, by Type, 2018 - 2030 (USD Million)
  • Table 17. U.S. Dermatological Drugs Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 18. U.S. Dermatological Drugs Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 19. U.S. Dermatological Drugs Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 20. Canada Dermatological Drugs Market, by Therapy, 2018 - 2030 (USD Million)
  • Table 21. Canada Dermatological Drugs Market, by Type, 2018 - 2030 (USD Million)
  • Table 22. Canada Dermatological Drugs Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 23. Canada Dermatological Drugs Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 24. Canada Dermatological Drugs Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 25. Mexico Dermatological Drugs Market, by Therapy, 2018 - 2030 (USD Million)
  • Table 26. Mexico Dermatological Drugs Market, by Type, 2018 - 2030 (USD Million)
  • Table 27. Mexico Dermatological Drugs Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 28. Mexico Dermatological Drugs Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 29. Mexico Dermatological Drugs Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 30. Europe Dermatological Drugs Market, by Country, 2018 - 2030 (USD Million)
  • Table 31. Europe Dermatological Drugs Market, by Therapy, 2018 - 2030 (USD Million)
  • Table 32. Europe Dermatological Drugs Market, by Type, 2018 - 2030 (USD Million)
  • Table 33. Europe Dermatological Drugs Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 34. Europe Dermatological Drugs Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 35. Europe Dermatological Drugs Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 36. UK Dermatological Drugs Market, by Therapy, 2018 - 2030 (USD Million)
  • Table 37. UK Dermatological Drugs Market, by Type, 2018 - 2030 (USD Million)
  • Table 38. UK Dermatological Drugs Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 39. UK Dermatological Drugs Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 40. UK Dermatological Drugs Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 41. Germany Dermatological Drugs Market, by Therapy, 2018 - 2030 (USD Million)
  • Table 42. Germany Dermatological Drugs Market, by Type, 2018 - 2030 (USD Million)
  • Table 43. Germany Dermatological Drugs Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 44. Germany Dermatological Drugs Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 45. Germany Dermatological Drugs Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 46. France Dermatological Drugs Market, by Therapy, 2018 - 2030 (USD Million)
  • Table 47. France Dermatological Drugs Market, by Type, 2018 - 2030 (USD Million)
  • Table 48. France Dermatological Drugs Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 49. France Dermatological Drugs Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 50. France Dermatological Drugs Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 51. Italy Dermatological Drugs Market, by Therapy, 2018 - 2030 (USD Million)
  • Table 52. Italy Dermatological Drugs Market, by Type, 2018 - 2030 (USD Million)
  • Table 53. Italy Dermatological Drugs Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 54. Italy Dermatological Drugs Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 55. Italy Dermatological Drugs Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 56. Spain Dermatological Drugs Market, by Therapy, 2018 - 2030 (USD Million)
  • Table 57. Spain Dermatological Drugs Market, by Type, 2018 - 2030 (USD Million)
  • Table 58. Spain Dermatological Drugs Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 59. Spain Dermatological Drugs Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 60. Spain Dermatological Drugs Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 61. Denmark Dermatological Drugs Market, by Therapy, 2018 - 2030 (USD Million)
  • Table 62. Denmark Dermatological Drugs Market, by Type, 2018 - 2030 (USD Million)
  • Table 63. Denmark Dermatological Drugs Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 64. Denmark Dermatological Drugs Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 65. Denmark Dermatological Drugs Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 66. Sweden Dermatological Drugs Market, by Therapy, 2018 - 2030 (USD Million)
  • Table 67. Sweden Dermatological Drugs Market, by Type, 2018 - 2030 (USD Million)
  • Table 68. Sweden Dermatological Drugs Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 69. Sweden Dermatological Drugs Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 70. Sweden Dermatological Drugs Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 71. Norway Dermatological Drugs Market, by Therapy, 2018 - 2030 (USD Million)
  • Table 72. Norway Dermatological Drugs Market, by Type, 2018 - 2030 (USD Million)
  • Table 73. Norway Dermatological Drugs Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 74. Norway Dermatological Drugs Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 75. Norway Dermatological Drugs Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 76. Asia Pacific Dermatological Drugs Market, by Country, 2018 - 2030 (USD Million)
  • Table 77. Asia Pacific Dermatological Drugs Market, by Therapy, 2018 - 2030 (USD Million)
  • Table 78. Asia Pacific Dermatological Drugs Market, by Type, 2018 - 2030 (USD Million)
  • Table 79. Asia Pacific Dermatological Drugs Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 80. Asia Pacific Dermatological Drugs Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 81. Asia Pacific Dermatological Drugs Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 82. Japan Dermatological Drugs Market, by Therapy, 2018 - 2030 (USD Million)
  • Table 83. Japan Dermatological Drugs Market, by Type, 2018 - 2030 (USD Million)
  • Table 84. Japan Dermatological Drugs Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 85. Japan Dermatological Drugs Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 86. Japan Dermatological Drugs Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 87. China Dermatological Drugs Market, by Therapy, 2018 - 2030 (USD Million)
  • Table 88. China Dermatological Drugs Market, by Type, 2018 - 2030 (USD Million)
  • Table 89. China Dermatological Drugs Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 90. China Dermatological Drugs Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 91. China Dermatological Drugs Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 92. India Dermatological Drugs Market, by Therapy, 2018 - 2030 (USD Million)
  • Table 93. India Dermatological Drugs Market, by Type, 2018 - 2030 (USD Million)
  • Table 94. India Dermatological Drugs Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 95. India Dermatological Drugs Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 96. India Dermatological Drugs Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 97. Australia Dermatological Drugs Market, by Therapy, 2018 - 2030 (USD Million)
  • Table 98. Australia Dermatological Drugs Market, by Type, 2018 - 2030 (USD Million)
  • Table 99. Australia Dermatological Drugs Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 100. Australia Dermatological Drugs Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 101. Australia Dermatological Drugs Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 102. South Korea Dermatological Drugs Market, by Therapy, 2018 - 2030 (USD Million)
  • Table 103. South Korea l Dermatological Drugs Market, by Type, 2018 - 2030 (USD Million)
  • Table 104. South Korea Dermatological Drugs Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 105. South Korea Dermatological Drugs Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 106. South Korea Dermatological Drugs Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 107. Thailand Dermatological Drugs Market, by Therapy, 2018 - 2030 (USD Million)
  • Table 108. Thailand Dermatological Drugs Market, by Type, 2018 - 2030 (USD Million)
  • Table 109. Thailand Dermatological Drugs Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 110. Thailand Dermatological Drugs Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 111. Thailand Dermatological Drugs Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 112. Latin America Dermatological Drugs Market, by Country, 2018 - 2030 (USD Million)
  • Table 113. Latin America Dermatological Drugs Market, by Therapy, 2018 - 2030 (USD Million)
  • Table 114. Latin America Dermatological Drugs Market, by Type, 2018 - 2030 (USD Million)
  • Table 115. Latin America Dermatological Drugs Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 116. Latin America Dermatological Drugs Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 117. Latin America Dermatological Drugs Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 118. Brazil Dermatological Drugs Market, by Therapy, 2018 - 2030 (USD Million)
  • Table 119. Brazil Dermatological Drugs Market, by Type, 2018 - 2030 (USD Million)
  • Table 120. Brazil Dermatological Drugs Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 121. Brazil Dermatological Drugs Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 122. Brazil Dermatological Drugs Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 123. Argentina Dermatological Drugs Market, by Therapy, 2018 - 2030 (USD Million)
  • Table 124. Argentina Dermatological Drugs Market, by Type, 2018 - 2030 (USD Million)
  • Table 125. Argentina Dermatological Drugs Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 126. Argentina Dermatological Drugs Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 127. Argentina Dermatological Drugs Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 128. Middle East & Africa Dermatological Drugs Market, by Country, 2018 - 2030 (USD Million)
  • Table 129. Middle East & Africa Dermatological Drugs Market, by Therapy, 2018 - 2030 (USD Million)
  • Table 130. Middle East & Africa Dermatological Drugs Market, by Type, 2018 - 2030 (USD Million)
  • Table 131. Middle East & Africa Dermatological Drugs Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 132. Middle East & Africa Dermatological Drugs Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 133. Middle East & Africa Dermatological Drugs Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 134. South Africa Dermatological Drugs Market, by Therapy, 2018 - 2030 (USD Million)
  • Table 135. South Africa Dermatological Drugs Market, by Type, 2018 - 2030 (USD Million)
  • Table 136. South Africa Dermatological Drugs Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 137. South Africa Dermatological Drugs Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 138. South Africa Dermatological Drugs Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 139. Saudi Arabia Dermatological Drugs Market, by Therapy, 2018 - 2030 (USD Million)
  • Table 140. Saudi Arabia Dermatological Drugs Market, by Type, 2018 - 2030 (USD Million)
  • Table 141. Saudi Arabia Dermatological Drugs Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 142. Saudi Arabia Dermatological Drugs Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 143. Saudi Arabia Dermatological Drugs Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 144. UAE Dermatological Drugs Market, by Therapy, 2018 - 2030 (USD Million)
  • Table 145. UAE Dermatological Drugs Market, by Type, 2018 - 2030 (USD Million)
  • Table 146. UAE Dermatological Drugs Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 147. UAE Dermatological Drugs Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 148. UAE Dermatological Drugs Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 149. Kuwait Dermatological Drugs Market, by Therapy, 2018 - 2030 (USD Million)
  • Table 150. Kuwait Dermatological Drugs Market, by Type, 2018 - 2030 (USD Million)
  • Table 151. Kuwait Dermatological Drugs Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 152. Kuwait Dermatological Drugs Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 153. Kuwait Dermatological Drugs Market, by Distribution Channel, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Dermatological Drugs Market Segmentation
  • Fig. 2 Market Research Process
  • Fig. 3 Data Triangulation Techniques
  • Fig. 4 Primary Research Pattern
  • Fig. 5 Market Research Approaches
  • Fig. 6 Value Chain-Based Sizing & Forecasting
  • Fig. 7 Market Formulation & Validation
  • Fig. 8 Market Snapshot

Fig. 9 Segment Outlook (USD Million)

  • Fig. 10 Competitive Landscape
  • Fig. 11 Dermatological Drugs Market Dynamics
  • Fig. 12 Dermatological Drugs Market: Porter's Five Forces Analysis
  • Fig. 13 Dermatological Drugs Market: Pestle Analysis
  • Fig. 14 Dermatological Drugs Market: Therapy Segment Dashboard
  • Fig. 15 Dermatological Drugs Market: Therapy Market Share Analysis, 2024 & 2030
  • Fig. 16 Acne Market (USD Million)
  • Fig. 17 Psoriasis Market (USD Million)
  • Fig. 18 Rosacea Market (USD Million)
  • Fig. 19 Alopecia Market (USD Million)
  • Fig. 20 Others Market, 2018 - 2030 (USD Million)
  • Fig. 21 Dermatological Drugs Market: Type Segment Dashboard
  • Fig. 22 Dermatological Drugs Market: Type Market Share Analysis, 2024 & 2030
  • Fig. 23 Prescription Market (USD Million)
  • Fig. 24 Over-the-counter (OTC) Market (USD Million)
  • Fig. 25 Dermatological Drugs Market: Route of Administration Segment Dashboard
  • Fig. 26 Dermatological Drugs Market: Route of Administration Market Share Analysis, 2024 & 2030
  • Fig. 27 Topical Administration Market (USD Million)
  • Fig. 28 Oral Administration Market (USD Million)
  • Fig. 29 Parenteral Administration Market (USD Million)
  • Fig. 30 Dermatological Drugs Market: Drug Class Segment Dashboard
  • Fig. 31 Dermatological Drugs Market: Drug Class Market Share Analysis, 2024 & 2030
  • Fig. 32 Corticosteroids Market (USD Million)
  • Fig. 33 Retinoids Market (USD Million)
  • Fig. 34 Antibiotics Market (USD Million)
  • Fig. 35 Antifungals Market (USD Million)
  • Fig. 36 Calcineurin Inhibitors Market (USD Million)
  • Fig. 37 Others Market, 2018 - 2030 (USD Million)
  • Fig. 38 Dermatological Drugs Market: Distribution Channel Segment Dashboard
  • Fig. 39 Dermatological Drugs Market: Distribution Channel Market Share Analysis, 2024 & 2030
  • Fig. 40 Hospital Pharmacies Market, 2018 - 2030 (USD Million)
  • Fig. 41 Retail Pharmacies Market, 2018 - 2030 (USD Million)
  • Fig. 42 Others Market, 2018 - 2030 (USD Million)
  • Fig. 43 Distance Correspondence Market, 2018 - 2030 (USD Million)
  • Fig. 44 Regional Marketplace: Key Takeaways
  • Fig. 45 North America Dermatological Drugs Market, 2018 - 2030 (USD Million)
  • Fig. 46 U.S. Country Dynamics
  • Fig. 47 U.S. Dermatological Drugs Market, 2018 - 2030 (USD Million)
  • Fig. 48 Canada Country Dynamics
  • Fig. 49 Canada Dermatological Drugs Market, 2018 - 2030 (USD Million)
  • Fig. 50 Mexico Country Dynamics
  • Fig. 51 Mexico Dermatological Drugs Market, 2018 - 2030 (USD Million)
  • Fig. 52 Europe Dermatological Drugs Market, 2018 - 2030 (USD Million)
  • Fig. 53 UK Country Dynamics
  • Fig. 54 UK Dermatological Drugs Market, 2018 - 2030 (USD Million)
  • Fig. 55 Germany Country Dynamics
  • Fig. 56 Germany Dermatological Drugs Market, 2018 - 2030 (USD Million)
  • Fig. 57 France Country Dynamics
  • Fig. 58 France Dermatological Drugs Market, 2018 - 2030 (USD Million)
  • Fig. 59 Italy Country Dynamics
  • Fig. 60 Italy Dermatological Drugs Market, 2018 - 2030 (USD Million)
  • Fig. 61 Spain Country Dynamics
  • Fig. 62 Spain Dermatological Drugs Market, 2018 - 2030 (USD Million)
  • Fig. 63 Denmark Country Dynamics
  • Fig. 64 Denmark Dermatological Drugs Market, 2018 - 2030 (USD Million)
  • Fig. 65 Sweden Country Dynamics
  • Fig. 66 Sweden Dermatological Drugs Market, 2018 - 2030 (USD Million)
  • Fig. 67 Norway Country Dynamics
  • Fig. 68 Norway Dermatological Drugs Market, 2018 - 2030 (USD Million)
  • Fig. 69 Asia Pacific Dermatological Drugs Market, 2018 - 2030 (USD Million)
  • Fig. 70 Japan Country Dynamics
  • Fig. 71 Japan Dermatological Drugs Market, 2018 - 2030 (USD Million)
  • Fig. 72 China Country Dynamics
  • Fig. 73 China Dermatological Drugs Market, 2018 - 2030 (USD Million)
  • Fig. 74 India Country Dynamics
  • Fig. 75 India Dermatological Drugs Market, 2018 - 2030 (USD Million)
  • Fig. 76 Australia Country Dynamics
  • Fig. 77 Australia Dermatological Drugs Market, 2018 - 2030 (USD Million)
  • Fig. 78 South Korea Country Dynamics
  • Fig. 79 South Korea Dermatological Drugs Market, 2018 - 2030 (USD Million)
  • Fig. 80 Thailand Country Dynamics
  • Fig. 81 Thailand Dermatological Drugs Market, 2018 - 2030 (USD Million)
  • Fig. 82 Latin America Dermatological Drugs Market, 2018 - 2030 (USD Million)
  • Fig. 83 Brazil Country Dynamics
  • Fig. 84 Brazil Dermatological Drugs Market, 2018 - 2030 (USD Million)
  • Fig. 85 Argentina Country Dynamics
  • Fig. 86 Argentina Dermatological Drugs Market, 2018 - 2030 (USD Million)
  • Fig. 87 MEA Dermatological Drugs Market, 2018 - 2030 (USD Million)
  • Fig. 88 South Africa Country Dynamics
  • Fig. 89 South Africa Dermatological Drugs Market, 2018 - 2030 (USD Million)
  • Fig. 90 Saudi Arabia Country Dynamics
  • Fig. 91 Saudi Arabia Dermatological Drugs Market, 2018 - 2030 (USD Million)
  • Fig. 92 UAE Country Dynamics
  • Fig. 93 UAE Dermatological Drugs Market, 2018 - 2030 (USD Million)
  • Fig. 94 Kuwait Country Dynamics
  • Fig. 95 Kuwait Dermatological Drugs Market, 2018 - 2030 (USD Million)
  • Fig. 96 Company Categorization
  • Fig. 97 Company Market Position Analysis
  • Fig. 98 Strategic Framework